Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation

specific

Prostate adenocarcinoma with neuroendocrine differentiation that has spread from its original site of growth to another anatomic site.

16

Centers

17

Active Trials

—

Cancer Funding

Top Centers for Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation(16)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
High-Volume Research Center
74.2
2
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
Active Research Program
51.7
3
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
Active Research Program
51.7
4
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
Active Research Program
51.7
5
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
51.7
6
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
Active Research Program
51.7
7
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
51.7
8
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
51.7
9
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
51.7
10
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
Active Research Program
51.7
11
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
51.7
12
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
Active Research Program
51.7
13
University of Illinois Cancer CenterChicago, IL
Active Research Program
51.7
14
Boston University Cancer CenterBoston, MA
Active Research Program
51.7
15
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
Active Research Program
51.7
16
Tampa General Hospital Cancer InstituteTampa, FL
Active Research Program
51.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →